mk 0852 has been researched along with gr 144053 in 1 studies
| Studies (mk 0852) | Trials (mk 0852) | Recent Studies (post-2010) (mk 0852) | Studies (gr 144053) | Trials (gr 144053) | Recent Studies (post-2010) (gr 144053) |
|---|---|---|---|---|---|
| 17 | 2 | 0 | 21 | 1 | 2 |
| Protein | Taxonomy | mk 0852 (IC50) | gr 144053 (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 0.0079 | |
| Integrin alpha-IIb | Homo sapiens (human) | 0.0079 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heptinstall, S; Storey, RF; Wilcox, RG | 1 |
1 trial(s) available for mk 0852 and gr 144053
| Article | Year |
|---|---|
Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists.
Topics: Adenosine Diphosphate; Anticoagulants; Citrates; Collagen; Eptifibatide; Hirudins; Humans; Nephelometry and Turbidimetry; Oligopeptides; Peptides; Peptides, Cyclic; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sodium Citrate; Thiazolidines | 1998 |